Subsequently, CD30 was shown to be highly expressed in both ALK+ and ALK- ALCL, as well as a number of other lymphoid cancers and proliferative disorders including cutaneous ALCL, mycosis fungoides, Sézary syndrome, lymphomatoid papulosis, and a subset of diffuse large B cell lymphomas [57–59]. Here, ALK is linked to Sezary syndrome.